胰岛素剂量调整在接受胰岛素泵治疗的2型糖尿病患者血糖控制中的应用

doi:10.13481/j.1671-587x.20180629

摘要/Abstract

摘要： 目的：比较不同方法对应用胰岛素泵治疗的2型糖尿病患者血糖达标时间、血糖波动、低血糖发生和胰岛素用量等方面的影响，寻找胰岛素泵治疗2型糖尿病患者时使血糖安全、快速和有效达标的最佳方法。方法：选择应用预混胰岛素治疗血糖控制不佳住院的60例2型糖尿病患者，按照随机数字表法随机分为传统治疗组、大剂量向导组和大剂量向导联合监测组，每组20例。传统治疗组患者根据医生的经验及指尖血糖监测情况调整胰岛素剂量；大剂量向导组患者根据胰岛素泵自带大剂量向导软件及指尖血糖监测情况调整血糖；大剂量向导联合监测组患者同时联合大剂量向导软件及实时动态血糖监测系统（RTCGM）对患者进行血糖调整。检测患者指尖血糖水平，采用血糖水平的标准差（SDBG）和最大血糖波动幅度（LAGE）评价患者血糖波动情况。记录3组患者血糖达标时间、3d内SDBG和LAGE、低血糖发生情况及治疗后胰岛素用量。结果：大量剂向导组患者平均血糖达标时间少于传统治疗组（t=2.30，P<0.05），大剂量向导联合监测组患者平均血糖达标时间少于大剂量向导组（t=3.50，P<0.05）。治疗第3天，大剂量向导组患者SDBG和LAGE明显小于传统治疗组（t_SDBG=3.11，t_LAGE=2.54，P<0.05），大剂量向导联合监测组患者LAGE明显小于大剂量向导组（t_LAGE=2.47，P<0.05）。3组患者总体低血糖事件（χ²=2.192，P=0.532）、显著低血糖事件（χ²=2.765，P=0.322）和夜间低血糖事件（χ²=2.192，P=0.532）发生情况比较差异无统计学意义。3组患者平均胰岛素用量（F=2.102，P=0.131）、达标日非基础胰岛素用量（χ²=2.328，P=0.107）和非基础胰岛素百分比（χ²=2.104，P=0.131）组间比较差异无统计学意义。结论：大剂量向导软件联合RTCGM治疗2型糖尿病疗效较好，且不增加低血糖风险、不增加胰岛素用量。

关键词: 胰岛素泵, 实时动态血糖监测, 大剂量向导, 血糖波动, 胰岛素

Abstract: Objective: To compare the effects of different methods on the glucose treat-to-target time,glucose fluctuation,hypoglycemia and insulin doses in the type 2 diabetic patients treated by insulin bump, and to find the best method to make the glucose to reach the standand level safely,fast and effectively in the type 2 diabetic patients treated by insulin bump.Methods: Sixty hospitalized type 2 diabetic patients inadequatly controlled by premix insulin treatment were randomly divided into convention group (n=20),Bolus Wizard group (n=20),and Bolus Wizard combined with monitoring(combination) group (n=20) according to the random number grouping method.The insulin doses of the patients in convention group were adjusted according to the glucose monitoring of fingertip and the doctor's experiences; the insulin doses of the patients in Bolus Wizard group were adjusted according to the Bolus Wizard software in insulin bump, and the glucose monitoring of fingertip; the insulin doses of the patients in combination group were adjusted according to the Bolus Wizard software combined with real time continuous glucose monitoring system(RTCGM). The level of fingertip glucose was tested.The standard deviation of blood glucose(SDBG)and largest amplitude of glycemic excursion(LAGE)were used to evaluate the glucose fluctuation of the patients in various groups. The treat-to-target time,glucose fluctuation,hypoglycemia and daily insulin doses of the patients in various groups were recorded.Results: Compared with convention group,the treat-to-target time of the patients in Bolus Wizard group was decreased(t=2.30,P<0.05);compared with Bolus Wizard group,the treat-to-target time of the patients in combination group was decreased(t=3.50,P<0.05).On the 3rd day of treatment, compared with convention group,the SDBG and LAGE of the patients in Bolus Wizard group were decreased(t_SDBG=3.11,t_LAGE=2.54,P<0.05); compared with Bolus Wizard group, the LAGE of the patients in combination group was decreased(t_LAGE=2.47,P<0.05).There were no significant differences in the incidence of total hypoglycemia events (χ²=2.192, P=0.532), significant hypoglycemia events (χ²=2.765, P=0.322) and nocturnal hypoglycemia events (χ²=2.192, P=0.532) among the patients in various groups; there were no significant differences in the average insulin dosage (F=2.102, P=0.131), the non-basic insulin dosage (χ²=2.328, P=0.107) and the percentage of non-basic insulin (χ²=2.104, P=0.131) among the patients in various groups.Conclusion: Bolus Wizard software combined with real-time dynamic RTCGM has better effect in the treatment of type 2 diabetes without increasing the risk of hypoglycemia and insulin dosage.

Key words: insulin bump, real time continuous glucose monitoring, Bolus Wizard, glucose fluctuation, insulin

中图分类号:

R587.1

董学美, 王丽娟, 沈鸿, 赵岩, 张秀娟, 乔月, 蔡寒青. 胰岛素剂量调整在接受胰岛素泵治疗的2型糖尿病患者血糖控制中的应用[J]. 吉林大学学报(医学版), 2018, 44(06): 1280-1285.

DONG Xuemei, WANG Lijuan, SHEN Hong, ZHAO Yan, ZHANG Xiujuan, QIAO Yue, CAI Hanqing. Application of insulin dose adjustment in blood glucose control in patients with type 2 diabetes treated by insulin pump[J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1280-1285.

参考文献

[1] 程文炜,闫晓芳,史静琤,等.基于GIS的中国中老年人糖尿病空间分布及其影响因素分析[J].中华疾病控制杂志,2017,21(9):1082-1087.
[2] Hinnen D, Strong J. iGlarLixi:A new once-daily fixed-ratio combination of basal insulin glargine and lixisenatide for the management of type 2 diabetes[J]. Diabetes Spectr, 2018, 31(2):145-154.
[3] Majedah M, Abdul R, Mohammad M, et al. A comparison of continuous subcutaneous insulin infusion vs multiple daily insulin injection in children with type Ⅰ diabetes in kuwait:glycemic control, insulin requirement, and BMI[J]. Oman Med J, 2015, 30(5):336-343.
[4] Al Hayek AA, Robert AA, Al Dawish, et al. Efficacy of insulin pump therapy on diabetes treatment satisfaction and glycemic control among patients with type 1 diabetes mellitus in saudi arabia:A prospective study[J]. Diabetes Ther, 2015, 6(2):227-236.
[5] 凌丽.不同方案胰岛素强化治疗2型糖尿病的临床效果观察[J].中国医学前沿杂志:电子版,2015,7(9):36-39.
[6] Ziegler R, Freckmann G, Heinemann L. Boluses in insulin therapy[J]. J Diabetes Sci Technol, 2017, 11(1):165-171.
[7] 荣义华,谷巍,耿建林,等.不同胰岛素皮下注射方案T2DM患者的血糖变异性比较[J]. 中国现代医学杂志,2017,27(17):103-107.
[8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志,2018,38(4):292-344.
[9] American Diabetes Association.Standards of medical care in diabetes-2017[J]. Diabetes Care, 2017, 40(Suppl1):S1-135.
[10] American Diabetes Association. Standards of medical care in diabetes-2016[J]. Diabetes Care, 2016, 39(Suppl1):S1-112.
[11] Neuhāuser M, Bretz F. Nonparametric all-Pairs mutiple comparisons[J]. Biom J,2015, 43(5):571-580.
[12] 刘春英,刘彩霞.采用胰岛素泵治疗2型糖尿病的疗效及对患者生活质量的影响[J].中国基层医药,2015,22(3):419-421.
[13] Piri S, Delen D, Liu TM, et al. Development of a new metric to identify rare patterns in association analysis:the case of analyzing diabetes complications[J]. Expert Syst Appl, 2018, 94(3):112-125.
[14] King A, Philis-Tsimikas A, Kilpatrick E. A fixed ratio combination of insulin degludec and liraglutide (IDegLira) reduces glycemic fluctuation and brings more patients with type 2 diabetes within blood glucose target ranges[J]. Diabetes Technol Ther, 2017, 4(19):255-264.
[15] McEwan P, Thorsted BL, Wolden M, et al.Healthcare resource implications of hypogly-cemia-related hospital admissions and inpatient hypoglycemia:retrospective record-linked cohort studies in England[J]. BMJ Open Diabetes Res Care, 2015, 3(1):e000057.
[16] Kakuta K, Dohi K, Miyoshi M, et al. Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus[J]. Cardiovasc Diabetol, 2017, 16(1):131.
[17] Johansen N, Christensen M. A systematic review on insulin overdose cases:clinical course, complications and treatment options[J]. Basic Clin Pharmacol Toxicol, 2018, 6(122):650-659.
[18] Giannoulaki P, Gounitsioti I, Iliadis F. Bolus wizard use has a beneficial effect in glycemic control among people with diabetes type 1 on insulin pump therapy[J].Clin Nutrit Espen, 2016, 6(13):e62-e63.
[19] Ziegler R, Rees C, Jacobs N, et al. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy:results of the Bolus Advisor Benefit Evaluation (BABE) study[J]. Pediatr Diabetes, 2016,17(5):311-318.
[20] Gu W, Liu Y, Chen Y, et al. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China:Time to reach target glucose[J]. Diabetes Metab, 2017, 43(4):359-363.
[21] 孙正凯,魏进,韩玉亭.动态血糖监测系统对2型糖尿病患者强化治疗中血糖波动监测的价值[J].山东医药,2016,56(37):69-71.
[22] Ziegler R, Rees C, Jacobs N, et al. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy:results of the Bolus Advisor Benefit Evaluation (BABE) study[J]. Pediatr Diabetes, 2016, 17(5):311-318.